Revs @ $167.6M, but headline of "down 5.3%" comparison vs guidance (flat to down 5% vs 3Q) slight negative, new buying opportunity for everyone, including Bd. of Directors!!
Sentiment: Strong Buy
I figured one could buy this sick puppy at $11.00, but it is not going to $6.00, the way sardonic #$%$ said. The bottom has moved up from $8.25 reached as an intrad-day low on July 23rd to somewhat over $9.00 a month or two ago.
SPIL also had a lower 4th quarter. But the price is well above the book value. Comparing the sale and book value to SPIL, IMOS should be around $22.
Valuation going from absurd to ludicrous. Time to step up pressure on management!